<DOC>
	<DOCNO>NCT01507441</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood , tissue , bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study DNA sample patient Down syndrome acute myeloid leukemia treat COG-AAML0431 clinical trial .</brief_summary>
	<brief_title>Studying DNA Samples From Younger Patients With Down Syndrome Acute Myeloid Leukemia Treated COG-AAML0431 Clinical Trial</brief_title>
	<detailed_description>OBJECTIVES : - To identify new genetic abnormality associate acute myeloid leukemia ( AML ) patient Down syndrome whole-genome sequencing . OUTLINE : This multicenter study . Extracted DNA RNA cryopreserved specimen analyze genomic sequencing , gene mutation , microarray analysis .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Down syndrome child diagnose acute myeloid leukemia ( AML ) myelodysplastic syndrome ( MDS ) Clinical sample patient enrol Children 's Oncology Group ( COG ) AAML0431 phase III clinical trial , Children 's Hospital Michigan Cell Bank Diagnostic blast sample match remission sample PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood myelodysplastic syndrome</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
	<keyword>childhood acute megakaryocytic leukemia ( M7 )</keyword>
</DOC>